Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management

被引：16

作者：

Ahmed, Kamran A. ^{[1
]}

Kim, Sungjune ^{[1
]}

Harrison, Louis B. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 26卷 / 03期

关键词：

Abscopal effect; Bystander effect; Immune checkpoint inhibitors; Radiation therapy; IMMUNOGENIC CELL-DEATH; BRAIN METASTASES; STEREOTACTIC RADIOSURGERY; IPILIMUMAB IMMUNOTHERAPY; CLINICAL-OUTCOMES; TUMOR-CELLS; OPEN-LABEL; CANCER; NIVOLUMAB; RADIOTHERAPY;

D O I：

10.1016/j.soc.2017.01.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunotherapy has revolutionized the systemic management of numerous malignancies. Nowhere has the proven benefit of these agents in clinical practice been more evident than in the management of advanced melanoma. Numerous preclinical studies have revealed the potential benefit of immune-priming radiotherapy in stimulating tumor-specific immune responses. This signal for immune activation may lead to clinically relevant synergy with immune checkpoint inhibitors against malignant cells. In this review, the authors summarize the current data outlining the role radiation therapy may play in the management of advanced melanoma alongside immune checkpoint inhibitors.

引用

页码：515 / +

页数：16

共 50 条

[31] Acute neurological adverse events during immune checkpoint inhibition therapy in patients with melanoma brain metastases [J].

Graetz, Victoria ;

Langan, Ewan A. ;

Neumann, Alexander ;

Zillikens, Detlef ;

Terheyden, Patrick .

MELANOMA RESEARCH, 2019, 29 (05) :516-521

[32] Advances in immune checkpoint inhibitors for bone sarcoma therapy [J].

Thanindratarn, Pichaya ;

Dean, Dylan C. ;

Nelson, Scott D. ;

Hornicek, Francis J. ;

Duan, Zhenfeng .

JOURNAL OF BONE ONCOLOGY, 2019, 15

[33] Immune Checkpoint Inhibitors in Cancer Therapy [J].

Shiravand, Yavar ;

Khodadadi, Faezeh ;

Kashani, Seyyed Mohammad Amin ;

Hosseini-Fard, Seyed Reza ;

Hosseini, Shadi ;

Sadeghirad, Habib ;

Ladwa, Rahul ;

O'Byrne, Ken ;

Kulasinghe, Arutha .

CURRENT ONCOLOGY, 2022, 29 (05) :3044-3060

[34] Drug therapy for myocarditis induced by immune checkpoint inhibitors [J].

Wu, Yihao ;

Xu, Yizhou ;

Xu, Linhao .

FRONTIERS IN PHARMACOLOGY, 2023, 14

[35] Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis [J].

Sha, Congzhou M. ;

Lehrer, Eric J. ;

Hwang, Clara ;

Trifiletti, Daniel M. ;

Mackley, Heath B. ;

Drabick, Joseph J. ;

Zaorsky, Nicholas G. .

RADIOTHERAPY AND ONCOLOGY, 2020, 151 :141-148

[36] Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review [J].

Li, Jiarui ;

Kan, Haoxuan ;

Zhao, Lin ;

Sun, Zhao ;

Bai, Chunmei .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12

[37] Immune Checkpoint Therapy in Melanoma [J].

Callahan, Margaret K. .

CANCER JOURNAL, 2016, 22 (02) :73-80

[38] Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan [J].

Wu, Chiao-En ;

Yang, Chan-Keng ;

Peng, Meng-Ting ;

Huang, Pei-Wei ;

Lin, Yu-Fen ;

Cheng, Chi-Yuan ;

Chang, Yao-Yu ;

Chen, Huan-Wu ;

Hsieh, Jia-Juan ;

Chang, John Wen-Cheng .

FRONTIERS IN ONCOLOGY, 2020, 10

[39] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges [J].

Liu, Xiufeng ;

Qin, Shukui .

ONCOLOGIST, 2019, 24 :S3-S10

[40] Biomarkers for immune Checkpoint inhibitors in Melanoma [J].

Kitano, Shigehisa ;

Nakayama, Takayuki ;

Yamashita, Makiko .

FRONTIERS IN ONCOLOGY, 2018, 8

← 1 2 3 4 5 →